GO
Loading...

Gilead Sciences Inc

More

  • TRENTON, N.J.— Drugmaker Bristol-Myers Squibb Co. said Thursday that an experimental combination of two hepatitis C drugs— its daclatasvir and Gilead Sciences Inc.' s blockbuster drug Sovaldi— cured hepatitis C in just 12 weeks in nearly all the patients, who also are infected with the HIV virus. David Wyles, an associate professor at University of...

  • Final Glance: Biotechnology companies Thursday, 26 Feb 2015 | 6:02 PM ET

    Amgen Inc. rose$. 89 or. 6 percent, to $158.97. Biogen Idec rose $1.16 or. 3 percent, to $410.10. Celgene Corp. rose$. 25 or. 2 percent, to $123.35.

  • Midday Glance: Biotechnology companies Thursday, 26 Feb 2015 | 1:19 PM ET

    Amgen Inc. rose$. 82 or. 5 percent, to $158.90. Biogen Idec rose$. 94 or. 2 percent, to $409.88. Celgene Corp. rose$. 03 or percent, to $123.13.

  • Early Glance: Biotechnology companies Thursday, 26 Feb 2015 | 10:35 AM ET

    Amgen Inc. fell $1.58 or 1.0 percent, to $156.50. Biogen Idec fell $2.44 or. 6 percent, to $406.50. Celgene Corp. fell $1.02 or. 8 percent, to $122.08.

  • Midday Glance: Biotechnology companies Wednesday, 25 Feb 2015 | 1:18 PM ET

    Amgen Inc. rose$. 76 or. 5 percent, to $158.13. Biogen Idec rose $5.19 or 1.3 percent, to $410.08. Celgene Corp. rose$. 26 or. 2 percent, to $123.44.

  • Early Glance: Biotechnology companies Wednesday, 25 Feb 2015 | 11:23 AM ET

    Amgen Inc. fell$. 12 or. 1 percent, to $157.25. Biogen Idec fell$. 90 or. 2 percent, to $403.99. Celgene Corp. fell$. 77 or. 6 percent, to $122.41.

  • Final Glance: Biotechnology companies Tuesday, 24 Feb 2015 | 6:02 PM ET

    Amgen Inc. fell $1.05 or. 7 percent, to $157.37. Biogen Idec fell $3.69 or. 9 percent, to $404.89. Celgene Corp. fell$. 64 or. 5 percent, to $123.18.

  • Midday Glance: Biotechnology companies Tuesday, 24 Feb 2015 | 1:17 PM ET

    Amgen Inc. fell $1.39 or. 9 percent, to $157.03. Biogen Idec fell $4.78 or 1.2 percent, to $403.80. Celgene Corp. fell $1.52 or 1.2 percent, to $122.30.

  • Early Glance: Biotechnology companies Tuesday, 24 Feb 2015 | 11:24 AM ET

    Amgen Inc. fell$. 48 or. 3 percent, to $157.94. Biogen Idec fell $1.79 or. 4 percent, to $406.80. Celgene Corp. fell $1.16 or. 9 percent, to $122.66.

  • Final Glance: Biotechnology companies Monday, 23 Feb 2015 | 6:04 PM ET

    Amgen Inc. rose$. 76 or. 5 percent, to $158.42. Biogen Idec rose$. 53 or. 1 percent, to $408.58. Celgene Corp. rose$. 39 or. 3 percent, to $123.82.

  • Midday Glance: Biotechnology companies Monday, 23 Feb 2015 | 1:20 PM ET

    Amgen Inc. rose$. 94 or. 6 percent, to $158.60. Biogen Idec rose$. 07 or percent, to $408.12. Celgene Corp. rose $1.13 or. 9 percent, to $124.56.

  • Early Glance: Biotechnology companies Monday, 23 Feb 2015 | 10:40 AM ET

    Amgen Inc. rose$. 91 or. 6 percent, to $158.57. Biogen Idec rose$. 73 or. 2 percent, to $408.78. Celgene Corp. rose $1.37 or 1.1 percent, to $124.80.

  • Final Glance: Biotechnology companies Friday, 20 Feb 2015 | 6:00 PM ET

    Amgen Inc. rose $1.61 or 1.0 percent, to $157.66. Biogen Idec rose $1.32 or. 3 percent, to $408.05. Celgene Corp. rose $3.22 or 2.7 percent, to $123.43.

  • Midday Glance: Biotechnology companies Friday, 20 Feb 2015 | 1:36 PM ET

    Amgen Inc. rose$. 53 or. 3 percent, to $156.58. Biogen Idec fell$. 39 or. 1 percent, to $406.35. Celgene Corp. rose $2.89 or 2.4 percent, to $123.10.

  • Early Glance: Biotechnology companies Friday, 20 Feb 2015 | 10:50 AM ET

    Amgen Inc. rose$. 78 or. 5 percent, to $156.83. Biogen Idec fell $1.22 or. 3 percent, to $405.51. Celgene Corp. rose $2.39 or 2.0 percent, to $122.60.

  • Final Glance: Biotechnology companies Thursday, 19 Feb 2015 | 6:03 PM ET

    Amgen Inc. rose$. 27 or. 2 percent, to $156.05. Biogen Idec rose $5.61 or 1.4 percent, to $406.73. Celgene Corp. rose $1.80 or 1.5 percent, to $120.21.

  • Midday Glance: Biotechnology companies Thursday, 19 Feb 2015 | 1:28 PM ET

    Amgen Inc. fell$. 60 or. 4 percent, to $155.18. Biogen Idec rose $4.72 or 1.2 percent, to $405.84. Celgene Corp. rose $1.72 or 1.5 percent, to $120.13.

  • Early Glance: Biotechnology companies Thursday, 19 Feb 2015 | 10:50 AM ET

    Amgen Inc. fell$. 24 or. 2 percent, to $155.54. Biogen Idec rose $3.29 or. 8 percent, to $404.41. Celgene Corp. rose $1.55 or 1.3 percent, to $119.96.

  • LOS ANGELES, Feb 19- As U.S. drugmakers face growing resistance to the high price of cutting-edge treatments, a handful of companies are working on a new payment model that rewards them for the long-term performance of their medicines. They include BioMarin Pharmaceutical Inc in San Rafael, California, and Sangamo BioSciences Inc in Richmond, California.

  • Final Glance: Biotechnology companies Wednesday, 18 Feb 2015 | 6:30 PM ET

    Amgen Inc. rose $1.54 or 1.0 percent, to $155.78. Biogen Idec rose $3.21 or. 8 percent, to $401.12. Celgene Corp. rose $2.09 or 1.8 percent, to $118.41.